Leadership

Tony Keating, Ph.D.

Chief Executive Officer and Managing Director

Tony has over 10 years’ experience in commercialising technology. Tony created the initial business strategy for ResApp and has led the commercialization of ResApp’s technology to date. Previously, Tony was Director, Commercial Engagement at UniQuest Pty Ltd, one of the global leaders in commercialisation of university technology. While at UniQuest, Tony held roles as interim Chief Executive Officer and Non-Executive Director for a number of privately-held, venture-capital funded start-up companies. Prior to joining UniQuest Tony held business development and engineering management roles at Exa Corporation, a US-based software company that is now listed on the NASDAQ.

Tony holds a Bachelor of Engineering, a Master of Engineering Science and a Doctor of Philosophy (Mechanical Engineering) from The University of Queensland. Tony also has an Executive Certificate of Management and Leadership from the MIT Sloan School of Management, and is a Graduate Member of the Australian Institute of Company Directors.

Brian Leedman

Vice President, Corporate Affairs

Brian is a marketing and investor relations professional with over 10 years’ experience in the biotechnology industry. Mr Leedman was co-founder of ResApp Diagnostics Pty Ltd which was acquired by Narhex Life Sciences Ltd to form ResApp Health. Prior to ResApp, Brian co-founded Oncosil Medical Limited and Biolife Science Limited (acquired by Imugene Limited). Brian previously served for 10 years as Vice President, Investor Relations for pSivida Corp which is listed on the ASX and NASDAQ.

Brian holds a Bachelor of Economics and a Masters of Business Administration from the University of Western Australia.

Mike Connell

Vice President, Commercial

Mike has over 30 years of commercial experience including 13 years of health leadership experience with GSK (Europe & Australia), Medibank (private health insurance) and consulting on a major global M&A project.

As VP & General Manager of GlaxoSmithKlines’s (GSK) Established Product Portfolio in Europe, Mike launched this business which delivered a significant share of the £3Bn in global sales during 2014. Prior to this Mike was VP & General Manager, GSK Denmark and VP & Head of the Thrombosis Centre of Excellence (global medical/marketing strategic team). Before moving to Europe, Mike held roles as Sales Director, Marketing Manager Metabolics and Hospital & Oncology Sales & Marketing Manager at GSK Australia. Prior to his pharmaceuticals experience, Mike had a diverse commercial background with significant strategy, product, sales and marketing experience across many industries, including utilities (gas & electricity – TRU Energy), textiles, sporting footwear & apparel (Nike) and fast food (Red Rooster).

Jamie Joint

Director, Sales and Marketing (Europe)

Jamie has over 20 years of experience in the medical device industry, building successful sales infrastructure and driving growth on a global scale. Prior to joining ResApp, Jamie was International Sales Director at MolecuLight, whose lead product is a CE Marked handheld point-of-care wound-imaging device. Prior to MolecuLight, the majority of Jamie’s career was spent at Olympus Medical where he held a number of senior sales and marketing roles in the UK, Middle East and Africa.

Al Rey Lunar, CPA

Vice President, Finance

Al is a Certified Practicing Accountant with over 18 years of experience across financial management, shared services, and external audit in a Big 4 firm. Prior to joining ResApp, Al was a Financial Controller for an ASX listed company in the healthcare sector with operations in Australia and overseas. Al has extensive experience in financial reporting under AIFRS, IFRS and US GAAP.

Al holds a Bachelor of Science in Accountancy Degree and is a candidate for Master of Business Administration.

ResApp Logo White

ResApp Health Limited
ABN 51 094 468 318
Level 12, 100 Creek St, Brisbane, QLD 4000

© 2021 ResApp Health Limited. All rights reserved. US Patent No. 10,098,569, Australian Patent No. 2013239327, Japanese Patent No. 6,435,257, South Korean Patent No. 1020812410000 and Patents Pending. ResApp Health®, the ResApp Health logo and ResAppDx® are registered trademarks of ResApp Health Limited in the United States and other countries. ResAppDx is not available for sale in the United States.